Clinical Trial Update: The Added Value of Hybrid Functional Anatomical Imaging PET-CT and SPECT-CT in Patients Treated With Y-90 SIRT for Liver Malignancies

View source ↗

Summary

This update reports findings from a completed trial evaluating the added value of PET-CT and SPECT-CT imaging in patients treated with Y-90 SIRT for liver malig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastases

Drugs mentioned

• SIR-Spheres Y-90 resin microspheres (yttrium-90 resin microspheres)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Primary Liver Tumor, Metastatic Liver | Status: COMPLETED